Omega Funds
Company: Omega Funds
Description: Omega Funds is a prominent international investment firm that specializes in creating and investing in life sciences companies aimed at addressing some of the most pressing medical needs around the globe. Established in 2004 and headquartered in Boston, Massachusetts, Omega Funds is committed to an investment strategy that prioritizes delivering impactful medicines to patients. The firm's approach involves a strong focus on investing in exceptional founders and entrepreneurs, as well as innovative products and platforms across a wide range of therapeutic areas. These include oncology, immunology, rare diseases, and precision medicine, among others.
The investment portfolio of Omega Funds encompasses a diverse range of strategies, from early seed financings to late-stage public offerings. The firm is willing to engage in investments within both large market sectors and niche rare diseases, thus demonstrating a versatile investment philosophy that is not confined by conventional categories. Omega Funds is guided by its confidence in people, products, and groundbreaking ideas, which allows it to navigate complex investment landscapes effectively. The firm employs a variety of financial instruments, including early venture rounds, late-stage investments, direct secondary transactions, as well as the founding and creation of new companies.
Since its inception, Omega Funds has successfully raised more than $2 billion, reinforcing its position as a leader in the venture capital and private equity sectors. Importantly, the firm is vigilant against potential scams and misrepresentations regarding job offers or recruitment opportunities. Omega Funds urges individuals to be cautious of unauthorized individuals claiming to represent the firm and recommends reporting any suspicious outreach to their team at jf@omegafunds.com for further investigation.
Industry: Venture Capital and Private Equity
Domain: http://www.omegafunds.com/
Founded: 2004
Location: Boston, Massachusetts
Address: 888 Boylston St, Boston, Massachusetts 02199, US
Size: 11-50 employees
Direct Contacts
Name: Noelle Hutchins
Title: Biotech VC Investor
Email: Direct Email
Company: Omega Funds
Phone: (617)-502-6530
Industry: Venture Capital and Private Equity
Location: Boston, Massachusetts
Name: Sean Cumiskey
Title: Head of Investor Relations
Email: Direct Email
Company: Omega Funds
Phone: (617)-502-6530
Industry: Venture Capital and Private Equity
Location: Boston, Massachusetts